Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
SAVA
SAVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SAVA News
Cassava Sciences Rebrands as Filana Therapeutics to Focus on CNS Disorders
2h ago
seekingalpha
Cassava Sciences Concludes DOJ Investigation into Research Misconduct
Feb 19 2026
stocktwits
Cassava Sciences Investigation Closed by DOJ
Feb 19 2026
seekingalpha
Cassava Technologies and AXON Networks Form Strategic Partnership
Jan 28 2026
Yahoo Finance
Cassava Sciences Faces Shareholder Rights Investigation by Halper Sadeh LLC
Dec 24 2025
PRnewswire
Cassava Sciences Inc. Settles Securities Class Action for $31.25 Million
Dec 23 2025
Benzinga
Cassava Sciences Settles $31.25 Million Securities Class Action Litigation
Dec 23 2025
Globenewswire
Cassava Sciences agrees to $31.25 million settlement in securities class action lawsuit
Dec 23 2025
SeekingAlpha
FDA Places Full Clinical Hold on Cassava's Simufilam Epilepsy Trial
Dec 19 2025
Benzinga
Cassava Sciences shares decline due to postponement of epilepsy research
Dec 19 2025
SeekingAlpha
Cassava Sciences Faces FDA Demand for Additional Data on Simufilam Study
Dec 03 2025
SeekingAlpha
Cassava Sciences Shares Surge 10% Post-Market Following CEO Stock Purchase
Nov 24 2025
SeekingAlpha
Cassava Sciences Soars After CEO Purchases Shares
Nov 21 2025
SeekingAlpha
Biotech Stocks Fluctuate Post-Market: Delcath Gains from Buyback, BioVie and Cassava Recover
Nov 21 2025
NASDAQ.COM
Cassava Sciences registers $200M mixed securities offering
Nov 13 2025
SeekingAlpha
Cassava announces court's dismissal of criminal charges against scientist
Oct 24 2025
SeekingAlpha
Show More News
